Symphony Clinical Research Earns WBENC Recertification for Fifth...
pharmatechoutlook

Symphony Clinical Research Earns WBENC Recertification for Fifth Consecutive Year

By Pharma Tech Outlook | Monday, April 01, 2019

Vernon Hills - Symphony Clinical Research, a business that specializes in in-home and alternate-site clinical research trial visits, received national recertification, for the fifth year in a row, as a Women’s Business Enterprise by the Women’s Business Development Center-Midwest, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC).

“Symphony is tremendously proud to be WBENC-Certified,” stated Nicki Norris, CEO at Symphony. “As a WBENC-Certified business, we recognize we are among a distinguished group of companies and are honored to continue to pave the way for women-owned businesses.”

The recertification process involved a questionnaire, as well as the submission of several legal forms that were used to assess Symphony and determine if we met all requirements of recertification. It is an in-depth and rigorous process that the entire team is proud to have achieved for another year.

There is an increasing importance in bringing recognition to women-owned businesses and celebrating their successes. The diversity that these companies bring to all industries should be nurtured, as to invoke future innovation.

Weekly Brief

New Editions